title: Yellow fever vaccine seroconversion in travelers.
abstract: To assess immunity after yellow fever (YF) 17D live-attenuated vaccination, we measured the antibody levels before vaccination and at 21 days and 8 months after vaccination in YF-naïve travelers. Thirty subjects were enrolled in the study, with 100% providing sera at 21 days and 86.6% providing sera at 8 months. All subjects seroconverted by day 21, and the geometric mean titers of the anti-YF antibodies decreased between day 21 and month 8 from 6,451 to 1,246. This study corroborates the high rates of seroconversion achieved by the live-attenuated YF vaccine.
authors: Mount Auburn Hospital, Cambridge, Massachusetts, USA. allison.h.kay@gmail.com
authors: Allison
authors: A
authors: Kay
authors: Lin H
authors: LH
authors: Chen
authors: Maggie
authors: M
authors: Sisti
authors: Thomas P
authors: TP
authors: Monath
mesh_terms: D000293:Adolescent; D000328:Adult; D000914:Antibodies, Viral / Q000097:blood; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D014195:Travel; D022341:Yellow Fever Vaccine / Q000008:administration & dosage* / Q000276:immunology; D055815:Young Adult
chemical_list: D000914:Antibodies, Viral; D022341:Yellow Fever Vaccine